E-Mail
IMAGE: Sumanta Pal, MD, a SWOG Cancer Research Network researcher and City of Hope physician, led a study that sets a new standard of care for metastatic papillary kidney cancer view more
Credit: City of Hope
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practice.
These findings will be presented at ASCO s virtual 2021 Genitourinary Cancers Symposium on Feb. 13, 2021 at 1 p.m. ET. The findings will be simultaneously published in
Press release content from Business Wire. The AP news staff was not involved in its creation.
Genprex Announces Formation of Clinical Advisory Board
February 8, 2021 GMT
AUSTIN, Texas (BUSINESS WIRE) Feb 8, 2021
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Clinical Advisory Board (CAB) to support its oncology and diabetes development programs. Comprised of preeminent clinical specialists, the CAB will lead and advise Genprex as it advances its REQORSA™ immunogene therapy program, including its Acclaim clinical trials in non-small cell lung cancer, and its preclinical diabetes gene therapy program. Some of the members also serve in additional roles at the Company.
Experts: COVID-19 variants may stall herd immunity, but double-masking could help
By (0)
Experts warn that variant strains of COVID-19 could slow or stall herd immunity in the United States, but wearing two masks may help prevent that from happening. File Photo by John Angelillo/UPI | License Photo
Feb. 3 (UPI) Hopes that the United States may be approaching herd immunity against COVID-19 may be dashed by the emergence of new variants of the virus, though expanding infection-control measures could solve that problem, experts said Wednesday.
With 26.4 million confirmed cases, and up to 10 times as many actually infected, the 32.8 million people vaccinated against the virus nationally through Tuesday could mean the country is close to herd immunity, according to immunologist David C. Montefiori.
People with a new, fast-spreading variant of the coronavirus are reporting more symptoms that those infected with the original strain. Here's what to know.